#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune-mediated myasthenia gravis Epilepsy Chronic myeloid leukaemia Acute myeloid leukaemia refractory Congenital nephrogenic diabetes insipidus Bulbospinal muscular atrophy congenital Neuroendocrine carcinoma of the skin Plasma cell myeloma recurrent Ichthyosis Progressive supranuclear palsy Hyperinsulinism Nasopharyngeal cancer Heart disease congenital Porphyria non-acute Conjunctivitis allergic More trials…

    Learn about Rare Diseases

    Haemolytic uraemic syndrome Behcet’s syndrome – Basic Information Paroxysmal nocturnal haemoglobinuria Mucopolysaccharidosis II – Basic Information MELAS syndrome – Trials in Disease Epidermolysis bullosa – Trials in Disease Antisynthetase syndrome – Diagnostics Primary hyperoxaluria – Diagnostics Aicardi-Goutieres syndrome – Diagnostics Propionic acidaemia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Esketamine Hydrochloride Rosnilimab Azelastine Hydrochloride Human Coagulation Factor X Regn7075 SGN-ALPV Loperamide M-(18F)-Fluorobenzylguanidine Rmc-035 Piritramide TETANUS TOXOID Tafluprost Florquinitau (18F) Lurbinectedin Triptorelin Acetate Other Blood Products Emicizumab Ima402 Dsimc Atorvastatin Calcium More therapies…

    Learn about Your Condition

    Dedifferentiated liposarcoma Mantle cell lymphoma Peripheral artery thrombosis Endocrine ophthalmopathy Tendon disorder Prostate cancer Renal cancer Mucopolysaccharidosis II Procedural headache Colon cancer stage IV Breast cancer recurrent Pelizaeus-Merzbacher disease Head and neck cancer Athetosis Solitary fibrous tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Thrombosis

  • Study on the Effect of Tinzaparin Sodium on Survival in Patients with Advanced Pancreatic Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Thrombosis
    • Tumour thrombosis
    Investigated Drugs:
    • Tinzaparin Sodium
    Greece

  • A study to compare the absorption of apixaban capsules and apixaban tablets in healthy volunteers to prevent thrombosis.

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Thrombosis
    Investigated Drugs:
    • Apixaban
    Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!